10:14 AM EDT, 05/21/2025 (MT Newswires) -- Alumis ( ALMS ) said Wednesday that it has completed its merger with Acelyrin ( SLRN ) .

Each Acelyrin ( SLRN ) shareholder will receive 0.4814 Alumis ( ALMS ) share for each Acelyrin ( SLRN ) share owned. Acelyrin ( SLRN ) shares have ceased trading on Nasdaq.

"This merger allows us to advance our pipeline through multiple planned key data readouts, with a cash runway that now extends into 2027," Alumis ( ALMS ) Chairman, CEO and President Martin Babler, said.

Alumis ( ALMS ) shares were up over 8% in recent trading.

Price: 5.28, Change: +0.40, Percent Change: +8.20